Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06004128
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-06-03
First Post:
2023-08-18
Brief Title:
Provide Pre-approval Single-patient Expanded Access Compassionate Use of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments
Sponsor:
Invivyd Inc
Organization:
Invivyd Inc
Organization Data
Organization:
Invivyd Inc
Class:
INDUSTRY
Study ID:
VYD222-EA-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Invivyd Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| In Expanded Access treating physicians are the Sponsors | AMBIG |